AFT Pharmaceuticals (AFP.AX) Earnings Analysis
AFT Pharmaceuticals (AFP.AX) has no confirmed upcoming earnings date. It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E 28.29.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AFP.AX next report earnings?
No confirmed upcoming earnings date is currently scheduled for AFP.AX. This page updates as the calendar is published.
AFP.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-21 | 0.09082 AUD | n/a | n/a | n/a |
| 2025-11-19 | 0.02755 AUD | n/a | n/a | n/a |
| 2025-05-21 | 0.1303 AUD | n/a | n/a | n/a |
| 2024-11-21 | -0.0181 AUD | 0.01376 AUD | -231.5% | Miss |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
AFP.AX valuation and analyst view
| Trailing P/E | 28.29 |
|---|---|
| Trailing EPS | 0.14046 AUD |
| Price / book | 3.80 |
| Dividend yield | 0.63% |
| Market cap | 0.35B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is AFT Pharmaceuticals (AFP.AX)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for AFP.AX. This page updates as the calendar is published.
Did AFP.AX beat earnings last quarter?
Consensus estimate data was not available for AFP.AX's 2026-05-21 report.
What is AFP.AX's earnings track record?
Over the last 1 reported quarters with consensus data, AFP.AX beat estimates 0 times (0%).
What is AFP.AX's current P/E ratio and EPS?
AFP.AX trades at a trailing P/E of 28.29 on trailing EPS of 0.1404646260865983 AUD.
What do analysts rate AFP.AX?
AFP.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.